Silyl modification of biologically active compounds. 12. Silyl group as true incentive to antitumour and antibacterial action of choline and colamine analogues

Applied Organometallic Chemistry

Volumn 20, Issue 11, 2006, Pages 721-728

  Zablotskaya, Alla ^a   Segal, Izolda ^a   Popelis, Yuris ^a   Lukevies, Edmunds ^a   Baluja, Shipra ^b   Shestakova, Irina ^a   Domracheva, Ilona ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b SAURASHTRA UNIVERSITY   (India)

Author keywords

Alkanolamines; Antimicrobial activity; Antirumour activity; Drug research; Organosilicon compounds

Indexed keywords

AMINES; BACTERIA; PARAFFINS; TUMORS;

ALKANOLAMINES; ANTIMICROBIAL ACTIVITY; ANTIRUMOUR ACTIVITY; DRUG RESEARCH; ORGANOSILICON COMPOUNDS;

DRUG PRODUCTS;

EID: 33750497437     PISSN: 02682605     EISSN: 10990739     Source Type: Journal    
DOI: 10.1002/aoc.1133     Document Type: Article

References (26)

1. Lukevics E, Zablotskaya A. Metalloorg. Khim. 1993; 6: 263.
2. Zablotskaya A, Germane S, Segal I, Lukevics E. Latv. Khim. Zhurn. 1993; 79.
3. Anderson W, Kasliwal R, Houston DM, Wang Y-S, Narayanan VL, Haugwitz RD, Plowman J. J. Med. Chem. 1995; 38: 3789.
4. Van Hattum AM, Pinedo HM, Schlueper HMM, Hausheer FH, Boven E. Int. J. Cancer 2000; 88: 260.
5. Gerlach M, Jutzi P, Stasch JP, Przuntek H. Z. Naturforch B: Anorg. Chem., Org. Chem. 1983; 38: 237.
6. Agarwal JC, Nath C, Gupta GP, Bhargava KP, Shanker K. Pharmacol. Res. Commun. 1981; 13:937.
7. Piekos R, Osmialowski K. Sci. Pharm. 1980; 48: 54.
8. Pitet G, Satgé J, Castel A, Stenger A, Lauressergues H, Rieu JP. Ann. Pharm. Franc. 1978; 36: 621.
9. Creveling CR, Daly JW, Tokuyama T, Witkop B. Experientia 1969; 25: 26.
10. Lukevics E, Zablotskaya A, Germane S. Segal I. Latv. Khim. Zhurn. 1994; 472.
11. Lukevics E, Segal I, Birgele I, Zablotskaya A. Chem. Heterocycl. Comp. 1998; 34:1076.
12. Zablotskaya A, Segal I, Germane S, Lukevics E, Spies H. Ann. Rep. FZR-312 2001; 66.
13. Zablotskaya A, Segal I, Germane S, Shestakova I, Domracheva I, Nesterova A, Geronikaki A, Lukevics E. Chem. Helcrocyd. Comp. 2002; 38: 859.
14. Zablotskaya A, Segal I, Kemme A, Germane S, Popelis J, Lukevics E, Berger R, Spies H. Chem. Heterocycl. Comp. 2002; 38: 477.
15. Kniess T, Spies H, Santos I, Zablocka A. J. Labelled Compd. Radiopharm. 2002; 45: 629.
16. Segal I, Zablotskaya A, Lukevics E. Chem. Heterocycl. Comp. 2005; 41: 613.
17. Zablotskaya A, Segal I, Belyakov S, Lukevics E. Appl. Organomet. Chem. 2006; 20: 149.
18. Lukevics E, Zablotskaya A, Segal I, Germane S, Popelis Ju. Chem. Heterocycl. Comp. 2003; 39: 813.
19. Lorand T, Kocsis B, Sonar P, Nagy G, Kispal G, Krane H-G, Schmitt H, Weckert E. Eur. J. Med. Chem. 2001; 36: 705.
20. Mashkovsky MD. Drugs, 12th edn. Medicina: Moscow, 1993.
21. Kourai H, Takechi H, Hone T, Uchiwa N, Takeichi K, Shibasaki I. J. Antibact. Antifung. Agents 1985; 13: 3.
22. Maeda T, Manabe Y, Yamamoto M, Yoshida M, Okazaki K, Nagamune H, Kourai H. Chem. Pharm. Bull. 1999; 47:1020.
23. Freshney PJ. Culture of Animal Cells (A Manual of Basic Technique). Wiley-Liss: New York, 1994; 296.
24. Fast DJ, Lynch RC, Leu RW. J. Leucocyt. Biol. 1992; 52: 255.
25. Perez C, Paul M, Bazerque P. Acta Biol. Med. Exp. 1990; 15:113.
26. Atta-Ur-Rahman, Choudhary MI, Thomsen WJ. Bioassay Techniques for Drug Development. Harwood Academic Publishers: Amsterdam, 2001; 16.